Laddar...
Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study
BACKGROUND: OnabotulinumtoxinA is effective in preventing chronic migraine (CM); however, the benefit of onabotulinumtoxinA in patients with CM with daily headache is unknown because these patients are typically excluded from clinical trials. This subanalysis of the COMPEL Study assessed the efficac...
Sparad:
| I publikationen: | J Headache Pain |
|---|---|
| Huvudupphovsmän: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer Milan
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6734507/ https://ncbi.nlm.nih.gov/pubmed/30709333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-018-0953-0 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|